Malaria

The device is targeted at severely ill malaria patients who have been hospitalised and prescribed IV drug treatment. These are the most vulnerable patients, including children, pregnant women and immune deficient patients, and can have mortality rates up to 20%.

Latest News

Finalist in MedTech London Awards 2019

Finalist in MedTech London Awards 2019
Created on 17-03-2019

We are delighted to be a finalist in the  Investment  category of this year’s MedTech London Awards...
MediSieve raises awareness ahead of World Malaria Day

MediSieve raises awareness ahead of World Malaria Day
Created on 07-03-2019

Medical technology firm MediSieve Ltd is highlighting its work for World Malaria Day on April 25 ...